The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Vagal Nerve Stimulators-Global Market Insights and Sales Trends 2024
Synopsis
Vagus nerve stimulation (VNS) is a medical treatment that involves delivering electrical impulses to the vagus nerve.
The global Vagal Nerve Stimulators market size is expected to reach US$ 1137.6 million by 2029, growing at a CAGR of 7.6% from 2023 to 2029. The market is mainly driven by the significant applications of Vagal Nerve Stimulators in various end use industries. The expanding demands from the Parkinson's disease, Epilepsy, Pain and Other, are propelling Vagal Nerve Stimulators market. Rechargeable spinal-cord stimulator, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-chargeable spinal-cord stimulator segment is estimated at % CAGR for the next seven-year period.
These devices are used for therapeutic purposes in neurology and pain management, delivering low-frequency electrical stimulation to targeted areas of the nervous system. The market growth can be attributed to several factors. Firstly, the increasing prevalence of neurological disorders and chronic pain conditions has created a demand for non-invasive and drug-free treatment options. Low-frequency sine wave neurostimulation therapy devices offer a safe and effective approach for managing these conditions, providing pain relief and improving overall quality of life for patients.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Vagal Nerve Stimulators, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Vagal Nerve Stimulators market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Vagal Nerve Stimulators market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Vagal Nerve Stimulators sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Vagal Nerve Stimulators covered in this report include Medtronic, Boston Scientific, Abbott, Truvaga Nerve Stimulation and NeuroPace, etc.
The global Vagal Nerve Stimulators market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Medtronic
Boston Scientific
Abbott
Truvaga Nerve Stimulation
NeuroPace
Global Vagal Nerve Stimulators market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Vagal Nerve Stimulators market, Segment by Type:
Rechargeable spinal-cord stimulator
Non-chargeable spinal-cord stimulator
Global Vagal Nerve Stimulators market, by Application
Parkinson's disease
Epilepsy
Pain
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Vagal Nerve Stimulators manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Vagal Nerve Stimulators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Vagus nerve stimulation (VNS) is a medical treatment that involves delivering electrical impulses to the vagus nerve.
The global Vagal Nerve Stimulators market size is expected to reach US$ 1137.6 million by 2029, growing at a CAGR of 7.6% from 2023 to 2029. The market is mainly driven by the significant applications of Vagal Nerve Stimulators in various end use industries. The expanding demands from the Parkinson's disease, Epilepsy, Pain and Other, are propelling Vagal Nerve Stimulators market. Rechargeable spinal-cord stimulator, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-chargeable spinal-cord stimulator segment is estimated at % CAGR for the next seven-year period.
These devices are used for therapeutic purposes in neurology and pain management, delivering low-frequency electrical stimulation to targeted areas of the nervous system. The market growth can be attributed to several factors. Firstly, the increasing prevalence of neurological disorders and chronic pain conditions has created a demand for non-invasive and drug-free treatment options. Low-frequency sine wave neurostimulation therapy devices offer a safe and effective approach for managing these conditions, providing pain relief and improving overall quality of life for patients.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Vagal Nerve Stimulators, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Vagal Nerve Stimulators market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Vagal Nerve Stimulators market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Vagal Nerve Stimulators sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Vagal Nerve Stimulators covered in this report include Medtronic, Boston Scientific, Abbott, Truvaga Nerve Stimulation and NeuroPace, etc.
The global Vagal Nerve Stimulators market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Medtronic
Boston Scientific
Abbott
Truvaga Nerve Stimulation
NeuroPace
Global Vagal Nerve Stimulators market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Vagal Nerve Stimulators market, Segment by Type:
Rechargeable spinal-cord stimulator
Non-chargeable spinal-cord stimulator
Global Vagal Nerve Stimulators market, by Application
Parkinson's disease
Epilepsy
Pain
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Vagal Nerve Stimulators manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Vagal Nerve Stimulators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Vagal Nerve Stimulators Market Overview
1.1 Vagal Nerve Stimulators Product Overview
1.2 Vagal Nerve Stimulators Market Segment by Type
1.2.1 Rechargeable spinal-cord stimulator
1.2.2 Non-chargeable spinal-cord stimulator
1.3 Global Vagal Nerve Stimulators Market Size by Type
1.3.1 Global Vagal Nerve Stimulators Market Size Overview by Type (2018-2029)
1.3.2 Global Vagal Nerve Stimulators Historic Market Size Review by Type (2018-2023)
1.3.3 Global Vagal Nerve Stimulators Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Vagal Nerve Stimulators Sales Breakdown by Type (2018-2023)
1.4.2 Europe Vagal Nerve Stimulators Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Vagal Nerve Stimulators Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Vagal Nerve Stimulators Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Vagal Nerve Stimulators Sales Breakdown by Type (2018-2023)
2 Global Vagal Nerve Stimulators Market Competition by Company
2.1 Global Top Players by Vagal Nerve Stimulators Sales (2018-2023)
2.2 Global Top Players by Vagal Nerve Stimulators Revenue (2018-2023)
2.3 Global Top Players by Vagal Nerve Stimulators Price (2018-2023)
2.4 Global Top Manufacturers Vagal Nerve Stimulators Manufacturing Base Distribution, Sales Area, Product Type
2.5 Vagal Nerve Stimulators Market Competitive Situation and Trends
2.5.1 Vagal Nerve Stimulators Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Vagal Nerve Stimulators Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vagal Nerve Stimulators as of 2022)
2.7 Date of Key Manufacturers Enter into Vagal Nerve Stimulators Market
2.8 Key Manufacturers Vagal Nerve Stimulators Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Vagal Nerve Stimulators Status and Outlook by Region
3.1 Global Vagal Nerve Stimulators Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Vagal Nerve Stimulators Historic Market Size by Region
3.2.1 Global Vagal Nerve Stimulators Sales in Volume by Region (2018-2023)
3.2.2 Global Vagal Nerve Stimulators Sales in Value by Region (2018-2023)
3.2.3 Global Vagal Nerve Stimulators Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Vagal Nerve Stimulators Forecasted Market Size by Region
3.3.1 Global Vagal Nerve Stimulators Sales in Volume by Region (2024-2029)
3.3.2 Global Vagal Nerve Stimulators Sales in Value by Region (2024-2029)
3.3.3 Global Vagal Nerve Stimulators Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Vagal Nerve Stimulators by Application
4.1 Vagal Nerve Stimulators Market Segment by Application
4.1.1 Parkinson's disease
4.1.2 Epilepsy
4.1.3 Pain
4.1.4 Other
4.2 Global Vagal Nerve Stimulators Market Size by Application
4.2.1 Global Vagal Nerve Stimulators Market Size Overview by Application (2018-2029)
4.2.2 Global Vagal Nerve Stimulators Historic Market Size Review by Application (2018-2023)
4.2.3 Global Vagal Nerve Stimulators Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Vagal Nerve Stimulators Sales Breakdown by Application (2018-2023)
4.3.2 Europe Vagal Nerve Stimulators Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Vagal Nerve Stimulators Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Vagal Nerve Stimulators Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Vagal Nerve Stimulators Sales Breakdown by Application (2018-2023)
5 North America Vagal Nerve Stimulators by Country
5.1 North America Vagal Nerve Stimulators Historic Market Size by Country
5.1.1 North America Vagal Nerve Stimulators Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Vagal Nerve Stimulators Sales in Volume by Country (2018-2023)
5.1.3 North America Vagal Nerve Stimulators Sales in Value by Country (2018-2023)
5.2 North America Vagal Nerve Stimulators Forecasted Market Size by Country
5.2.1 North America Vagal Nerve Stimulators Sales in Volume by Country (2024-2029)
5.2.2 North America Vagal Nerve Stimulators Sales in Value by Country (2024-2029)
6 Europe Vagal Nerve Stimulators by Country
6.1 Europe Vagal Nerve Stimulators Historic Market Size by Country
6.1.1 Europe Vagal Nerve Stimulators Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Vagal Nerve Stimulators Sales in Volume by Country (2018-2023)
6.1.3 Europe Vagal Nerve Stimulators Sales in Value by Country (2018-2023)
6.2 Europe Vagal Nerve Stimulators Forecasted Market Size by Country
6.2.1 Europe Vagal Nerve Stimulators Sales in Volume by Country (2024-2029)
6.2.2 Europe Vagal Nerve Stimulators Sales in Value by Country (2024-2029)
7 Asia-Pacific Vagal Nerve Stimulators by Region
7.1 Asia-Pacific Vagal Nerve Stimulators Historic Market Size by Region
7.1.1 Asia-Pacific Vagal Nerve Stimulators Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Vagal Nerve Stimulators Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Vagal Nerve Stimulators Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Vagal Nerve Stimulators Forecasted Market Size by Region
7.2.1 Asia-Pacific Vagal Nerve Stimulators Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Vagal Nerve Stimulators Sales in Value by Region (2024-2029)
8 Latin America Vagal Nerve Stimulators by Country
8.1 Latin America Vagal Nerve Stimulators Historic Market Size by Country
8.1.1 Latin America Vagal Nerve Stimulators Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Vagal Nerve Stimulators Sales in Volume by Country (2018-2023)
8.1.3 Latin America Vagal Nerve Stimulators Sales in Value by Country (2018-2023)
8.2 Latin America Vagal Nerve Stimulators Forecasted Market Size by Country
8.2.1 Latin America Vagal Nerve Stimulators Sales in Volume by Country (2024-2029)
8.2.2 Latin America Vagal Nerve Stimulators Sales in Value by Country (2024-2029)
9 Middle East and Africa Vagal Nerve Stimulators by Country
9.1 Middle East and Africa Vagal Nerve Stimulators Historic Market Size by Country
9.1.1 Middle East and Africa Vagal Nerve Stimulators Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Vagal Nerve Stimulators Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Vagal Nerve Stimulators Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Vagal Nerve Stimulators Forecasted Market Size by Country
9.2.1 Middle East and Africa Vagal Nerve Stimulators Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Vagal Nerve Stimulators Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Medtronic
10.1.1 Medtronic Company Information
10.1.2 Medtronic Introduction and Business Overview
10.1.3 Medtronic Vagal Nerve Stimulators Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Medtronic Vagal Nerve Stimulators Products Offered
10.1.5 Medtronic Recent Development
10.2 Boston Scientific
10.2.1 Boston Scientific Company Information
10.2.2 Boston Scientific Introduction and Business Overview
10.2.3 Boston Scientific Vagal Nerve Stimulators Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Boston Scientific Vagal Nerve Stimulators Products Offered
10.2.5 Boston Scientific Recent Development
10.3 Abbott
10.3.1 Abbott Company Information
10.3.2 Abbott Introduction and Business Overview
10.3.3 Abbott Vagal Nerve Stimulators Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Abbott Vagal Nerve Stimulators Products Offered
10.3.5 Abbott Recent Development
10.4 Truvaga Nerve Stimulation
10.4.1 Truvaga Nerve Stimulation Company Information
10.4.2 Truvaga Nerve Stimulation Introduction and Business Overview
10.4.3 Truvaga Nerve Stimulation Vagal Nerve Stimulators Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Truvaga Nerve Stimulation Vagal Nerve Stimulators Products Offered
10.4.5 Truvaga Nerve Stimulation Recent Development
10.5 NeuroPace
10.5.1 NeuroPace Company Information
10.5.2 NeuroPace Introduction and Business Overview
10.5.3 NeuroPace Vagal Nerve Stimulators Sales, Revenue and Gross Margin (2018-2023)
10.5.4 NeuroPace Vagal Nerve Stimulators Products Offered
10.5.5 NeuroPace Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Vagal Nerve Stimulators Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Vagal Nerve Stimulators Industrial Chain Analysis
11.4 Vagal Nerve Stimulators Market Dynamics
11.4.1 Vagal Nerve Stimulators Industry Trends
11.4.2 Vagal Nerve Stimulators Market Drivers
11.4.3 Vagal Nerve Stimulators Market Challenges
11.4.4 Vagal Nerve Stimulators Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Vagal Nerve Stimulators Distributors
12.3 Vagal Nerve Stimulators Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
